Target is approx $77
Was looking at this back in January at ~ $27/share, mentioned it again at $50/share, now might be the last big time to get in on the climb. Shoot your shots boys. NASDAQ:CRSP
CRSP is admittedly a VERY volatile name, but one with a big future and I believe a CL list stock at GS. On Friday, I was able to sell the May $45 puts for $1.90. If I am exercised, my cost basis will be $43.10, which puts it right in the support of the bottom of the last pullback. I would be OK getting exercised on that and I could exit for a small loss if it...
Anyone who knows me personally is cognisant of the fact that I hail from a pharmacy background that involves managing a community pharmacy in my day-to-day life. While this blog is focused on investing in macroeconomics and having a fundamental macroeconomic outlook, today I am heeding the advice of Peter Lynch; ‘‘you don’t have to go looking for investment...
Anyone who knows me personally is cognisant of the fact that I hail from a pharmacy background that involves managing a community pharmacy in my day-to-day life. While this blog is focused on investing in macroeconomics and having a fundamental macroeconomic outlook, today I am heeding the advice of Peter Lynch; ‘‘you don’t have to go looking for investment...
Really like CRSP, I like what it's about, but it's still speculative. I'll be a buyer if price lowers by 25%
This chart looked good in January when the market was on fire, and it still continues to look good despite hiccups along the way! Bullish.
CRSP continues to move within the next few weeks. Regards, JT
CRSP Gains, gains, more gains. Looking good so far this year. Gene editing seeking to cure diseases and cancer. Don't sleep on this one. Hitting some all time highs right now so wait for a moment to get down to the $22's and $21's and watch for a good return in the future.
Enough smart money may have entered the CRISPR/Cas field now.
Unconventional Median Line on the weekly. Pattern on watch. What is CRISPR? wwwuser.cnb.csic.es Informational only, not a recommendation to buy or sell any security.